No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Care Facilities
Wenzhou Kangning Hospital Co., Ltd. oversees and manages a broad array of healthcare facilities throughout the People's Republic of China. A core part of its mission involves providing specialized psychiatric care. The company's diverse operations also encompass real estate rental and sales, software development and IT solutions, hospital administration, forensic analysis, general medical provisions, and the retail of pharmaceutical products. Established in 1996, the organization was initially known as Wenzhou City Kangning Psychiatric Rehabilitation Hospital before officially adopting its current name, Wenzhou Kangning Hospital Co., Ltd., in October 2014. Its principal offices are situated in Wenzhou, PRC.
www.knhosp.cnNo one on the platform currently holds 2120.HK.
No tracked institution reports a position in 2120.HK as of their last filing.
No one on the platform has traded 2120.HK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 2.6% | 0.5% | 2.8% | — | — | — |
| Rev. Growth % | -2.1% | 10.4% | ||||
| Profit Margin % | 3.4% | 2.9% | 5.9% | |||
| Free Cash Flow Margin % | 15.1% | 3.1% | -4.7% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $833M | — | $1.18 | $1.18–$1.18 | — | 1 |
| 2028 | $1.1B | +29.8% | $1.26 | $1.26–$1.26 | — | 1 |
| 2029 | $1.1B | +3.2% | $1.11 | $1.11–$1.11 | — | 1 |
| 2030 | $1.5B | +38.1% | $1.29 | $1.29–$1.29 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 2120.HKWenzhou Kangning Hospital Co., Ltd. | $9.30 | +0.05% | $655M | — |
| 0239.HKPak Fah Yeow International Limited | $2.48 | +1.02% | $773M | — |
| 0690.HKUni-Bio Science Group Limited | $0.07 | +0.00% | $436M | — |
| 1228.HKCANbridge Pharmaceuticals Inc. | $1.92 | +2.67% | $816M | — |
| 1846.HKEuroEyes International Eye Clinic Limited | $2.30 | +0.00% | $735M | — |
| 3689.HKGuangdong Kanghua Healthcare Group Co., Ltd. | $1.90 | +0.00% |
Source: Financial Modeling Prep · peers by sector/industry
| $635M |
| — |
| 3869.HKHospital Corporation of China Limited | $3.40 | +0.00% | $464M | — |